arXiv · 2509.14972
An immuno-Infrared Sensor detects preclinical Alzheimer's and Parkinson's Disease by misfolding
Abstract
The immuno-infrared sensor detects target proteins in solution. Exemplary, the initial misfolding of amyloid beta (Abeta) peptides in blood is measured, enabling early risk prediction of Alzheimer's disease in the preclinical stage. Antibodies concentrate the target protein on the functionalized attenuated total reflection crystal surface. A quantum cascade laser is used to measure the amide I band, which indicates the secondary structure distribution of Abeta in blood as a biomarker.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Grischa Gerwert, Marvin Mann, Lennart Langenhoff, Nathalie Woitzik, Diana Hubert, Deniz Duman, Adrian Hoeveler, Sandy Budde, Jonas Simon, Leon Beyer, Martin Schuler, Sandrina Weber, Brit Mollenhauer, Carsten Kötting, Joern Gueldenhaupt, Klaus Gerwert. 2025-09-18. An immuno-Infrared Sensor detects preclinical Alzheimer's and Parkinson's Disease by misfolding. https://arxiv.org/abs/2509.14972
Cite the original work for its findings. Save a collection to share your selection of sources.